Pre-Market Stock News (May 31, 2007)

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

(AGE) A.G.Edwards gets an $89.50 buyout from Wachovia (WB) in cash and stock.
(AGIX) AtheroGenics announces business plan to focus on advancing AGI-1067 in diabetes.
(ASML) ASML will return 960 million Euros to shareholders in combination with an 8 for 9 split.
(BLI) Big Lots $0.26 EPS vs $0.20e.
(BRCD) Brocade is paying a $7 million SEC fine to settle its options backdating issue.
(CIEN) Ciena $0.26 EPS vs $0.25e; sees revenues up 3% in Q3 and sees 2007 revenue growth up to 36% from prior range of 27% to 30%.
(CLF) Cleveland Cliffs noted as takeover candidate by Jim Cramer on Mad Money.
(CONN) Conn’s $0.54 EPS vs $0.48e.
(COST) CostCo $0.56 EPS vs $0.56e; R$14.66B vs $14.68B(e).
(CRTX) Critical Therapeutics says FDA approves it’s ANDA for a twice-daily Zyflo CR extended-release tablets for asthma.
(FMX) FEMSA trades ex-split today to reflect its 3 for 1 stock split.
(HRAY) Hurray CFO/Co-Founder Jesse Liu will resign from his management role in the company at Hurray Holding.
(JTX) Jackson Hewitt $2.04 EPS vs. $1.93 estimate.
(LAYN) Layne Christensen $0.52 EPS vs $0.37e; unsure if comparable.
(MEDX) Medarex announced collaborative research pact with Mitsubishi Pharma.
(MGRM) Monogram announced it will release data on its biomarkers for breast cancer at ASCO.
(MOT) Motorola announced 4,000 layoffs in what is turning into an 11-yearrestructuring plan.
(MYL) Mylan Labs announced tentative FDA approval for its ANDA of paroxetine hydrochloride extended-release tablets.
(NOVL) Novell traded up 3% after beating earnings expectations.
(NRG) NRG Energy trades ex-split Tomorrow (Friday) and will reflect its 2 for 1 split then.
(VSEA) Varian Semi trades ex-split to reflect its 3 for 2 stock split today.
(WLP) (WLP) WellPoint CFO is resigning due to code of conduct violations
(WYE) Wyeth received FDA approval for its mTOR inhibitor for advanced kidney cancer.

Jon C. Ogg
May 31, 2007

Jon Ogg can be reached at [email protected]; he does not own securities in the companies he covers.

Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618